Skip to main content

Lymphadenopathy clinical trials at UC Health
2 research studies open to eligible people

  • Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma

    open to eligible males ages 16 years and up

    This phase II trial studies how well retroperitoneal lymph node dissection (RPLND) works in treating patients with stage I-IIa testicular seminoma. The retroperitoneum is the space in the body behind the intestines that is typically the first place that seminoma spreads. RPLND is a surgery that removes lymph nodes in this area to treat testicular seminoma and may experience fewer long-term toxicities, such as a second cancer, cardiovascular disease, metabolic syndrome (pre-diabetes), or lung disease.

    at UCSF

  • S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

    open to eligible people ages 18 years and up

    This phase II trial studies how well isatuximab works in treating patients with primary amyloidosis that has come back or does not respond to treatment. Monoclonal antibodies, such as isatuximab, may interfere with the ability of cancer cells to grow and spread.

    at UC Davis UC Irvine

Last updated: